IL18 and macrophage activation syndrome: In this study, we demonstrated that in CpG-induced MAS, inhibition of the NLRP3 inflammasome resulted in a reduction in plasma levels of IL-18, indicating that the NLRP3 inflammasome was the source of raised amounts of IL-18 in CpG-induced MAS.